Anavex Life Sciences Corp (AVXL)

[blu_1]

From your vast, comprehensive knowledge of prior Alzheimers trials to date, do you recall any trials where participants unanimously requested to be kept on the drug beyond the end of the trial? The Anavex 2-73 Ph 2A participants made such a request not once, but twice. Anavex complied with both requests, extending the trial from 6 mos to 1 year initially, and then granting a 2 yr extension to the formal Ph 2A trial. Those extensions were not planned by Anavex, they were accommodations to patient requests.